Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy
Status:
Unknown status
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
To asess the efficacy of Uroxatrol, an alpha blocker in men undergoing prostate brachytherapy
to treat prostate cancer, and whether the use of Uroxatrol in advance of the brachytherapy is
better or not than starting it on the day of surgery.